Study of a Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Adjuvanted Inactivated Vaccine in Healthy Adults (COVID-19)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04866069 |
|
Recruitment Status :
Terminated
(Although cellular responses to virus were satisfactory, neutralizing titres against virus were lower then expected levels)
First Posted : April 29, 2021
Last Update Posted : April 18, 2023
|
Sponsor:
Osman ERGANIS, PhD, Prof
Collaborators:
The Scientific and Technological Research Council of Turkey
VETAL Inc.
MonitorCRO
Information provided by (Responsible Party):
Osman ERGANIS, PhD, Prof, The Scientific and Technological Research Council of Turkey
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | September 5, 2021 |
| Actual Study Completion Date : | September 5, 2021 |